|
|

Title: Chewable tablets containing mannitol and aspartame
United States Patent: 6,296,868
Inventors: Valentine; William (Lawrenceville, GA); Valentine;
William K. (Lawrenceville, GA)
Assignee: Advanced Technology Pharmaceuticals Corporation
(Dacula, GA)
Appl. No.: 195811
Filed: November 19, 1998
Abstract
Chewable tablets and particulate food and pharmaceutical products are
disclosed which are made from agglomerates comprising an alcohol sugar
such as mannitol and a high intensity sweetener such as Aspartame from
which agglomerate tablets may be directly compressed, and processes for
making the agglomerates and tablets. The tablets or particulate product
containing the agglomerate may contain active ingredients blended with the
agglomerate or as part of the agglomerate structure. Tablets and
particulate products according to the invention can contain active
ingredients such as pharmaceuticals (e.g., antacids, analgesics, cough
medicine, drugs, etc.) breath sweeteners, vitamins and dietary
supplements, to name a few. The high intensity sweetener containing
agglomerates can also be used to make solid food mix type products such as
sugar free ice tea mixes.
SUMMARY OF The INVENTION
The above and other objects and advantages, which will be apparent to
those skilled in the art, are achieved in the present invention which is
directed to, in a broad aspect, an agglomerate sweetener composition
comprising an alcohol sugar such as mannitol and a high intensity
sweetener. The agglomerate typically has a porous, high surface area
void-like structure and is preferably made using a fluidized bed process.
The agglomerates preferably comprise mannitol as the alcohol sugar and
Aspartame as the high intensity sweetener. A water soluble binder is used
to form the agglomerate and is selected from the group consisting of an
alcohol sugar which can be the same as the alcohol sugar forming the base
of the composition, a water soluble carbohydrate, maltodextrin,
polyvinylpyrrolidone and carboxy methyl cellulose (CMC) among others. The
preferred binders are the same alcohol sugar forming the base and
maltodextrin.
The quantity of water-soluble binder is an effective amount needed to form
the agglomerate and is in the range of up to about 10 percent by weight of
the agglomerate,(including the high intensity sweetener), and preferably
from about 1 percent to about 5 percent. The alcohol sugar particles
comprise about 80 percent to about 97 percent and the high intensity
sweetener about 1 percent to 10 percent by weight of the agglomerate
(including the high intensity sweetener). The ranges vary depending on the
product in which the agglomerate is to be used. The particle size of the
materials used to make the agglomerates and the particulate size of the
agglomerates may likewise vary widely as described below.
A tablet made according to the present invention is directly compressed
from the high surface area porous alcohol sugar based high intensity
sweetener agglomerate particles preferably using a relatively low
tabletting pressure to form a relatively soft, quick-liquefying interior
and a relatively hard, protective outer shell which resists liquefaction
even though it is formed from the same agglomerate particles which form
the tablet interior. At least some of the ingredients of the agglomerate
particles jn the interior of the tablet quickly dissolve or partially
dissolve when the tablet is broken into pieces and contacted with small
amounts of a liquid, particularly water and/or saliva, as during
mastication for example, and any remaining ingredients which do not
dissolve in the liquid become dispersed in the liquid and dissolved
ingredients, so that the resulting liquid is smooth and essentially
without perceivable grit. The relatively hard outer shell resists
liquefaction until it is broken, for example, by chewing. Accordingly, the
overall preferred chewable tablet structure is such that the tablet is
storage stable and easily portable, thereby providing a unit dose in a
most convenient form, but is also readily liquefied and melts in the
saliva of the mouth during mastication without requiring water or some
other liquid, so that the tablet provides all of the benefits normally
associated only with liquid dosage forms.
Quick-liquifying, chewable tablets are shown in U.S. Pat. No. 4,684,534,
which patent is incorporated herein by reference and which patent is
assigned to the assignee of the present invention. The patent discloses
carbohydrate-based agglomerates, a method for making the agglomerates and
tablets made from the agglomerate.
The storage stable high intensity sweetener containing agglomerate
comprises an alcohol sugar, high intensity sweetener and a water-soluble
binder. The agglomerate may be used in food products without an active
ingredient. Typically the agglomerate is used with an active ingredient
such as in an ice tea mix or an antacid tablet. The agglomerate is
preferably blended with an active ingredient in the formulation. The
active ingredient and agglomerate can also be mixed together to;cause the
active ingredient to be entrained by and dispersed in the agglomerate.
This agglomerate can then be added to the product formulation. The active
ingredient can also be formed as part of the agglomerate during the
agglomeration process. The high intensity sweetener can be absorbed onto a
water-soluble agglomerate but this method and agglomerate composition are
not preferred.
The agglomerate as formed has a bulk density which is relatively low
compared to the alcohol sugar base and high intensity sweetener which are
used to make the agglomerate and is typically in the range of about 0.35
gm/cc to about 0.55 gm/cc. A substantial part of the agglomerate consists
of voids, i.e., pores or ducts, which provide an extremely large surface
area capable of entraining and dispersing substantial quantities of active
ingredients ordinarily about 10 percent to about 50 percent by weight of
the finished agglomerate (which includes the entrained active ingredient).
The agglomerate has particular utility as a direct compression agglomerate
from which tablets according to the invention can be made particularly
chewable tablets which liquify in saliva.
A preferred process for making the alcohol sugar and high intensity
sweetener agglomerate comprises the steps of forming a fluidized bed of
the alcohol sugar and high intensity sweetener particles, intermittently
spraying a solution of the water soluble binder in a droplet size into the
fluidized bed so as to cause intimate commingling of solution, alcohol
sugar and high intensity sweetener particles and adhesion together of
alcohol sugar particles and high intensity sweetener particles to form
agglomerated particles, drying the particles in the fluidized bed between
intermittent sprayings, and continuing spraying and drying until the
desired amount of binder solution has been sprayed into the bed.
Thereafter, the agglomerated particles are dried to a desired moisture
content or the equilibrium moisture content. The amount of liquid binder
solution sprayed corresponds to a binder content in the agglomerate of
from about 1 percent to about 10 percent by weight to the agglomerate. The
alcohol sugar and high intensity sweetener agglomerate and active
ingredient and other ingredients such as lubricants, flavors, etc. are
mixed, preferably in a low shear blender, to form a blend for tabletting
by direct compression or for use as a flowable food or pharmaceutical
product.
The agglomerate composition can also be made using a granulating procedure
whereby the alcohol sugar, high intensity sweetener and binder are mixed
together to form a paste like material, screened, dried and sized.
The agglomerate can, as formed, be used to entrain the active ingredient
and other materials such as a lubricant and flavors in the formulation to
be made into a product. In addition, an agglomerate containing the active
ingredient as part of the agglomerate structure can be formed by the
process described above for the agglomerate formed without an active
ingredient, except that the active ingredient is mixed with the alcohol
sugar and high intensity sweetener particles and a fluidized bed is formed
of this mixture. The active ingredient and/or high intensity sweetener may
also be added with the binder. Agglomerates formed with an active
ingredient have a porous structure similar to that of agglomerates formed
without an active ingredient.
The preferred method to form the agglomerate is by a fluidized bed process
wherein the alcohol sugar and high intensity sweetener are fluidized and a
binder solution sprayed onto the fluidized bed.
It is preferred that the alcohol sugar particles used to make the
agglomerate pass about 50 mesh (particle size less than about 300
microns). The high intensity sweetener typically passes about 300 mesh
(particle size less than about 50 microns). Mesh sizes given therein refer
to the U.S. Standard Sieve Series. The final particle size of the
agglomerate is preferably greater than about 80 mesh (111 microns).
A process for making a tablet from the alcohol sugar-high intensity
sweetener agglomerates described above, typically including about 0.4
percent to about 1 percent of a lubricant, comprises compressing the
agglomerate particles which were mixed with any active ingredient,
flavors, etc., in a conventional tablet-forming apparatus to a hardness
sufficient to hold the tablet together and preferably substantially
destroy the open pore structure of the agglomerate at the surface of the
tablet while substantially maintaining the open pore, i.e., large surface
area, structure of the agglomerate in the interior of the tablet. Thus,
the agglomerate is compressed so that the interior of the tablet
preferably retains the essential porous structure and other physical
characteristics of the agglomerate which enable it to liquify quickly,
while the physical characteristics of the agglomerate are changed
primarily at the surface of the tablet.
For the materials described herein, it has been found that the tablets are
preferably compressed to a hardness generally about 3 kp to about 8 kp or
higher, preferably about 6 kp, which compression forms an interior which
essentially retains the physical structure of the agglomerate. A thinner
outer shell is preferred since more force is required to break a tablet
with a thicker shell and less material is provided in the interior of a
tablet having a thicker shell. Since the thickness of the outer shell has
been found to increase with tablet hardness, a preferred range for
compression of the agglomerate is a hardness of about 3 kp to about 6 kp.
Pressures applied to compress the agglomerates into tablets having a
hardness of about 3 kp to 6 kp were found to be in the order of about
one-third the pressures ordinarily used to make tablets.
The term "high intensity sweetener" is used herein in a broad
sense and encompasses any high intensity sweetener material which can be
formed into an agglomerate or entrained in an agglomerate. The preferred
high intensity sweetener is Aspartame but other high intensity sweeteners
such as Acesulfame, Alatame, Steviasides, saccharin, cyclamates, etc., may
also be employed to make the agglomerate high intensity sweetener
composition of the invention. The term "active ingredient" is
used herein in a broad sense and means a pharmaceutical such as an
arntacid, analgesic or drug; or a flavor, breath sweetener, vitamin,
dietary supplement, or nutrient; or the like and combinations thereof.
Active ingredients include but are not limited to food acids; insoluble
metal and mineral hydroxides, carbonates, oxides, polycarbophils and salts
thereof; adsorbates of active drugs on a magnesium trisilicate base and on
a magnesium aluminum silicate base.
Claim 1 of 16 Claims
Thus, having described the invention, what is claimed is:
1. An agglomerate particulate intense sweetener composition comprising an
alcohol sugar and an intense sweetener wherein the particles have voids
therein and a bulk density lower than the alcohol sugar and intense
sweetener components.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|